Patrick Jozef Maria Smits, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arteriovenous Malformations | 8 | 2023 | 396 | 2.000 |
Why?
|
| MAP Kinase Kinase 1 | 4 | 2023 | 332 | 0.970 |
Why?
|
| Vascular Malformations | 4 | 2023 | 468 | 0.940 |
Why?
|
| Cartilage | 4 | 2018 | 806 | 0.860 |
Why?
|
| Chondrocytes | 7 | 2018 | 795 | 0.800 |
Why?
|
| Achondroplasia | 1 | 2018 | 28 | 0.600 |
Why?
|
| Bone Development | 2 | 2018 | 472 | 0.520 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2020 | 1246 | 0.500 |
Why?
|
| High Mobility Group Proteins | 3 | 2006 | 177 | 0.480 |
Why?
|
| ras Proteins | 1 | 2020 | 1054 | 0.480 |
Why?
|
| Endothelial Cells | 5 | 2023 | 3549 | 0.480 |
Why?
|
| Golgi Apparatus | 2 | 2012 | 405 | 0.440 |
Why?
|
| Embryo Loss | 1 | 2012 | 55 | 0.420 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 5 | 2021 | 1745 | 0.420 |
Why?
|
| Alleles | 4 | 2021 | 6864 | 0.350 |
Why?
|
| Vesicular Transport Proteins | 1 | 2012 | 376 | 0.340 |
Why?
|
| Nuclear Proteins | 4 | 2018 | 5799 | 0.330 |
Why?
|
| Osteochondrodysplasias | 1 | 2010 | 182 | 0.310 |
Why?
|
| Codon, Nonsense | 1 | 2010 | 285 | 0.310 |
Why?
|
| Arteriovenous Fistula | 2 | 2021 | 319 | 0.290 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2020 | 899 | 0.260 |
Why?
|
| Hemangioma | 2 | 2020 | 727 | 0.240 |
Why?
|
| Lymphedema | 2 | 2021 | 525 | 0.240 |
Why?
|
| Phenotype | 5 | 2020 | 16592 | 0.220 |
Why?
|
| Embryo, Mammalian | 2 | 2012 | 1674 | 0.220 |
Why?
|
| Notochord | 1 | 2003 | 37 | 0.220 |
Why?
|
| Growth Plate | 1 | 2004 | 274 | 0.200 |
Why?
|
| Receptor, EphB4 | 1 | 2021 | 39 | 0.190 |
Why?
|
| Receptor, TIE-2 | 1 | 2021 | 176 | 0.190 |
Why?
|
| Mutation | 11 | 2023 | 30053 | 0.190 |
Why?
|
| Sturge-Weber Syndrome | 1 | 2021 | 89 | 0.180 |
Why?
|
| Osteoblasts | 2 | 2018 | 1143 | 0.160 |
Why?
|
| DNA, Complementary | 1 | 2022 | 1991 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 2 | 2018 | 1342 | 0.160 |
Why?
|
| Cartilage Diseases | 1 | 2020 | 157 | 0.150 |
Why?
|
| Signal Transduction | 2 | 2020 | 23447 | 0.150 |
Why?
|
| DNA-Binding Proteins | 3 | 2006 | 9610 | 0.150 |
Why?
|
| Proteoglycans | 2 | 2015 | 803 | 0.150 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 328 | 0.150 |
Why?
|
| Transcription Factors | 4 | 2006 | 12130 | 0.140 |
Why?
|
| Capillaries | 1 | 2020 | 755 | 0.140 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2019 | 366 | 0.130 |
Why?
|
| SOXD Transcription Factors | 3 | 2006 | 44 | 0.130 |
Why?
|
| Cell Differentiation | 4 | 2010 | 11530 | 0.130 |
Why?
|
| Congenital Abnormalities | 1 | 2020 | 709 | 0.130 |
Why?
|
| Point Mutation | 1 | 2020 | 1595 | 0.120 |
Why?
|
| Mice | 11 | 2023 | 81539 | 0.120 |
Why?
|
| Enzyme Activation | 1 | 2020 | 3597 | 0.120 |
Why?
|
| Osteoclasts | 1 | 2018 | 711 | 0.110 |
Why?
|
| Mice, Knockout | 4 | 2018 | 14417 | 0.110 |
Why?
|
| Arthritis, Experimental | 1 | 2015 | 291 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2020 | 1486 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 1423 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7593 | 0.100 |
Why?
|
| Vasodilation | 1 | 1995 | 962 | 0.090 |
Why?
|
| Vasodilator Agents | 1 | 1995 | 973 | 0.090 |
Why?
|
| Animals | 12 | 2023 | 168475 | 0.090 |
Why?
|
| Adenosine | 1 | 1995 | 808 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 17904 | 0.090 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 2057 | 0.080 |
Why?
|
| Introns | 1 | 2012 | 981 | 0.080 |
Why?
|
| Exons | 2 | 2012 | 2391 | 0.080 |
Why?
|
| Osteolysis | 1 | 2010 | 275 | 0.080 |
Why?
|
| Cartilage, Articular | 1 | 2015 | 1099 | 0.080 |
Why?
|
| Homozygote | 1 | 2012 | 1776 | 0.070 |
Why?
|
| Genes, Recessive | 1 | 2010 | 623 | 0.070 |
Why?
|
| Knee Joint | 1 | 2015 | 1676 | 0.070 |
Why?
|
| Protein Transport | 1 | 2012 | 1967 | 0.070 |
Why?
|
| Bone and Bones | 2 | 2010 | 2568 | 0.070 |
Why?
|
| Glycosylation | 1 | 2010 | 1097 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 1749 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 1995 | 2136 | 0.070 |
Why?
|
| Heterozygote | 1 | 2012 | 2787 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2020 | 18966 | 0.060 |
Why?
|
| Receptors, Notch | 1 | 2010 | 744 | 0.060 |
Why?
|
| Cell Proliferation | 4 | 2010 | 10451 | 0.060 |
Why?
|
| Chondrogenesis | 1 | 2005 | 239 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 1134 | 0.060 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2004 | 58 | 0.060 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2004 | 106 | 0.050 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2004 | 158 | 0.050 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2004 | 191 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 1995 | 4431 | 0.050 |
Why?
|
| Joints | 1 | 2005 | 322 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2006 | 838 | 0.050 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2004 | 327 | 0.050 |
Why?
|
| Mesoderm | 1 | 2005 | 674 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2012 | 4142 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2004 | 561 | 0.050 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2021 | 36 | 0.050 |
Why?
|
| Synovial Membrane | 1 | 2005 | 532 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 1974 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 2735 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2004 | 768 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 4740 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2004 | 842 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2004 | 2677 | 0.040 |
Why?
|
| Humans | 16 | 2021 | 761596 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 2919 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 2529 | 0.040 |
Why?
|
| Time Factors | 2 | 2012 | 39969 | 0.040 |
Why?
|
| Pregnancy | 2 | 2012 | 29890 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2005 | 2557 | 0.030 |
Why?
|
| Cell Division | 1 | 2004 | 4465 | 0.030 |
Why?
|
| Tolbutamide | 1 | 1995 | 23 | 0.030 |
Why?
|
| omega-N-Methylarginine | 1 | 1995 | 108 | 0.030 |
Why?
|
| Quinidine | 1 | 1995 | 52 | 0.030 |
Why?
|
| Plethysmography | 1 | 1995 | 175 | 0.030 |
Why?
|
| Nitroprusside | 1 | 1995 | 272 | 0.030 |
Why?
|
| Verapamil | 1 | 1995 | 242 | 0.030 |
Why?
|
| Adolescent | 5 | 2021 | 88326 | 0.030 |
Why?
|
| Gestational Age | 1 | 2004 | 3577 | 0.030 |
Why?
|
| Female | 10 | 2021 | 392705 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 2425 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 2822 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2004 | 2856 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2872 | 0.030 |
Why?
|
| Forearm | 1 | 1995 | 427 | 0.030 |
Why?
|
| Cell Survival | 1 | 2003 | 5791 | 0.030 |
Why?
|
| Male | 8 | 2021 | 360846 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1995 | 537 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1995 | 908 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2021 | 6075 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 1995 | 1496 | 0.020 |
Why?
|
| Arginine | 1 | 1995 | 934 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 3617 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 15936 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2006 | 22174 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 9469 | 0.020 |
Why?
|
| Prognosis | 2 | 2020 | 29629 | 0.020 |
Why?
|
| Proteins | 1 | 2004 | 6032 | 0.020 |
Why?
|
| Young Adult | 3 | 2020 | 59260 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 1588 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2004 | 7859 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2010 | 629 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 2016 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2010 | 1341 | 0.020 |
Why?
|
| Adult | 4 | 2021 | 221210 | 0.020 |
Why?
|
| Chimera | 1 | 2006 | 453 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 3713 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2010 | 3614 | 0.010 |
Why?
|
| Integrases | 1 | 2006 | 518 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 10766 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3810 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4576 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 21019 | 0.010 |
Why?
|
| Synovial Fluid | 1 | 2005 | 393 | 0.010 |
Why?
|
| Hindlimb | 1 | 2005 | 513 | 0.010 |
Why?
|
| Surface Properties | 1 | 2005 | 1161 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 1229 | 0.010 |
Why?
|
| Child | 2 | 2020 | 80158 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1900 | 0.010 |
Why?
|
| Joint Diseases | 1 | 2005 | 459 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13510 | 0.010 |
Why?
|
| Syndrome | 1 | 2005 | 3267 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2006 | 2665 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 3088 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 42232 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 41495 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 18255 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 6534 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 5790 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 9490 | 0.010 |
Why?
|
| Radiography | 1 | 2005 | 6965 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 16990 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 220921 | 0.000 |
Why?
|